NEW YORK (GenomeWeb News) – An exclusive agreement with NewBridge Pharmaceuticals will enable molecular diagnostics firm Genomic Health to expand the market for its flagship breast and colon cancer recurrence test Oncotype DX into Africa, the Middle East, and surrounding regions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.